Beam Therapeutics Inc (BEAM)
21.66
-1.08
(-4.75%)
USD |
NASDAQ |
Apr 25, 11:59
Beam Therapeutics Total Liabilities (Quarterly): 478.38M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 478.38M |
| September 30, 2023 | 511.59M |
| June 30, 2023 | 542.24M |
| March 31, 2023 | 570.85M |
| December 31, 2022 | 608.24M |
| September 30, 2022 | 635.77M |
| June 30, 2022 | 618.21M |
| March 31, 2022 | 624.33M |
| December 31, 2021 | 647.72M |
| September 30, 2021 | 302.74M |
| Date | Value |
|---|---|
| June 30, 2021 | 344.53M |
| March 31, 2021 | 270.81M |
| December 31, 2020 | 206.12M |
| September 30, 2020 | 78.20M |
| June 30, 2020 | 69.15M |
| March 31, 2020 | 61.24M |
| December 31, 2019 | 55.15M |
| September 30, 2019 | 43.83M |
| June 30, 2019 | 36.90M |
| December 31, 2018 | 32.98M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
36.90M
Minimum
Jun 2019
647.72M
Maximum
Dec 2021
352.95M
Average
344.53M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 53.14B |
| Moderna Inc | 4.572B |
| Pfizer Inc | 137.21B |
| Editas Medicine Inc | 150.06M |
| Intellia Therapeutics Inc | 250.81M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.460B |
| Shareholders Equity (Quarterly) | 981.33M |
| Current Ratio | 5.891 |